申请人:American Home Products Corporation
公开号:US04788306A1
公开(公告)日:1988-11-29
There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen, hydroxy, lower alkyl, lower alkoxy, haloloweralkyl, haloloweralkyl sulfonyl, halo or nitro; R.sup.3 is hydrogen, lower alkyl, or aryl of 7-12 carbon atoms; ##STR2## A is --CH.sub.2 --, --O-- or --S--; m is 1-8; n is 0-7, with the proviso that m+n.ltoreq.8; or a pharmacologically acceptable salt thereof, and their use as fatty acid oxidation inhibitors possessing a significantly reduced potential for impairment of normal cardiac function, and having particular utility in the treatment of glucose and fatty acid metabolism disorders, such as diabetes.
公开了以下式子的化合物:##STR1## 其中R.sup.1和R.sup.2各自独立地为氢、羟基、较低的烷基、较低的烷氧基、卤代较低的烷基、卤代较低的烷基磺酰基、卤素或硝基;R.sup.3为氢、较低的烷基或含7-12个碳原子的芳基;##STR2## A为--CH.sub.2 --、--O--或--S--;m为1-8;n为0-7,但m+n≤8;或其药学上可接受的盐,以及它们作为脂肪酸氧化抑制剂,具有明显降低正常心脏功能损害的潜力,并在治疗葡萄糖和脂肪酸代谢紊乱(如糖尿病)方面具有特殊的用途。